Fund Investors
  • Home
  • Who we are
    • Who we are
    • History
    • Founding principles
    • Team
    • Strategies
      • Strategies
      • Flagship
      • Mid Cap
      • NextGen
    • Fund investor base
  • Investments
  • Sustainability
    • Sustainability
    • Responsible company
    • Responsible investor
  • Careers
  • Shareholders
    • Shareholders
    • Reports & presentations
    • Governance
    • Shareholder meetings
    • Stock information
  • Media
    • Our news
    • Financial news
    • Press
  • Contact
Antin logo

Share Price 8.55€ (-2.29 %)

Fund Investors
Antin logo
  • Who we are
    • History
    • Founding principles
    • Team
    • Strategies
    • Fund investor base
  • Investments
  • Sustainability
    • Responsible company
    • Responsible investor
  • Careers
  • Shareholders
    • Reports & presentations
    • Governance
    • Shareholder meetings
    • Stock information
  • Media
    • Our news
    • Financial news
    • Press
  • Contact
Black and white image of a long and empty meeting room table

Antin to acquire Emsere, a global leader in clinical trial equipment infrastructure

Archive

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014

seeing potential | delivering value

© 2026 Antin Infrastructure Partners

  • Terms & conditions
  • Policies & statements
  • Regulatory disclosures
  • LinkedIn